Kwanghee Jun

TL;DR: The aim of this study was to develop the Korean Anticholinergic Burden Scale through assessment of previously developed tools, a literature review and a modified Delphi process.

TL;DR: It was shown that high anticholinergic burden negatively affected the treatment response to cholinesterase inhibitors and that an average ACB score >3 was an independent prognostic factor for delirium or mortality in dementia patients.

TL;DR: It is demonstrated that a high anticholinergic burden in older adults increased the risk of all-cause emergency department visits, antICHolinergic ED visits and specific-cause ED visits.

TL;DR: This study showed that potentially significant DDIs with oral antineoplastic agents were prevalent in real-world practice, and recognizing the high prevalence of DDIs among patients taking oral anticancer agents is a necessary step toward improving the clinical outcome.

TL;DR: This study confirmed the dose response relationship for cumulative anticholinergic burden measured using the Korean specific anticholergic burden scale with incident dementia.